These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 19586054)

  • 1. A triple-emission fluorescent probe reveals distinctive amyloid fibrillar polymorphism of wild-type alpha-synuclein and its familial Parkinson's disease mutants.
    Celej MS; Caarls W; Demchenko AP; Jovin TM
    Biochemistry; 2009 Aug; 48(31):7465-72. PubMed ID: 19586054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric fluorescence detection of early stages in the amyloid protein aggregation of pyrene-labeled alpha-synuclein.
    Thirunavukkuarasu S; Jares-Erijman EA; Jovin TM
    J Mol Biol; 2008 May; 378(5):1064-73. PubMed ID: 18433772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative morphological analysis reveals ultrastructural diversity of amyloid fibrils from alpha-synuclein mutants.
    van Raaij ME; Segers-Nolten IM; Subramaniam V
    Biophys J; 2006 Dec; 91(11):L96-8. PubMed ID: 16997873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid-state NMR reveals structural differences between fibrils of wild-type and disease-related A53T mutant alpha-synuclein.
    Heise H; Celej MS; Becker S; Riedel D; Pelah A; Kumar A; Jovin TM; Baldus M
    J Mol Biol; 2008 Jul; 380(3):444-50. PubMed ID: 18539297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggregation-defective alpha-synuclein mutants inhibit the fibrillation of Parkinson's disease-linked alpha-synuclein variants.
    Koo HJ; Choi MY; Im H
    Biochem Biophys Res Commun; 2009 Aug; 386(1):165-9. PubMed ID: 19501571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of Cu(II) to human alpha-synucleins: comparison of wild type and the point mutations associated with the familial Parkinson's disease.
    Hong L; Simon JD
    J Phys Chem B; 2009 Jul; 113(28):9551-61. PubMed ID: 19548659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper- and iron-induced differential fibril formation in alpha-synuclein: TEM study.
    Bharathi ; Indi SS; Rao KS
    Neurosci Lett; 2007 Sep; 424(2):78-82. PubMed ID: 17714865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of the molecular chaperone alphaB-crystallin with alpha-synuclein: effects on amyloid fibril formation and chaperone activity.
    Rekas A; Adda CG; Andrew Aquilina J; Barnham KJ; Sunde M; Galatis D; Williamson NA; Masters CL; Anders RF; Robinson CV; Cappai R; Carver JA
    J Mol Biol; 2004 Jul; 340(5):1167-83. PubMed ID: 15236975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
    Conway KA; Harper JD; Lansbury PT
    Biochemistry; 2000 Mar; 39(10):2552-63. PubMed ID: 10704204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlling aggregation propensity in A53T mutant of alpha-synuclein causing Parkinson's disease.
    Kumar S; Sarkar A; Sundar D
    Biochem Biophys Res Commun; 2009 Sep; 387(2):305-9. PubMed ID: 19580781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The newly discovered Parkinson's disease associated Finnish mutation (A53E) attenuates α-synuclein aggregation and membrane binding.
    Ghosh D; Sahay S; Ranjan P; Salot S; Mohite GM; Singh PK; Dwivedi S; Carvalho E; Banerjee R; Kumar A; Maji SK
    Biochemistry; 2014 Oct; 53(41):6419-21. PubMed ID: 25268550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Explorations of the application of cyanine dyes for quantitative alpha-synuclein detection.
    Volkova KD; Kovalska VB; Segers-Nolten GM; Veldhuis G; Subramaniam V; Yarmoluk SM
    Biotech Histochem; 2009 Apr; 84(2):55-61. PubMed ID: 19267288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isomers of human alpha-synuclein stabilized by disulfide bonds exhibit distinct structural and aggregative properties.
    Jiang C; Chang JY
    Biochemistry; 2007 Jan; 46(2):602-9. PubMed ID: 17209570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards multiparametric fluorescent imaging of amyloid formation: studies of a YFP model of alpha-synuclein aggregation.
    van Ham TJ; Esposito A; Kumita JR; Hsu ST; Kaminski Schierle GS; Kaminski CF; Dobson CM; Nollen EA; Bertoncini CW
    J Mol Biol; 2010 Jan; 395(3):627-42. PubMed ID: 19891973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermodynamics imprinting reveals differential binding of metals to alpha-synuclein: relevance to Parkinson's disease.
    Bharathi ; Rao KS
    Biochem Biophys Res Commun; 2007 Jul; 359(1):115-20. PubMed ID: 17531952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial Parkinson disease mutations influence α-synuclein assembly.
    Ono K; Ikeda T; Takasaki J; Yamada M
    Neurobiol Dis; 2011 Sep; 43(3):715-24. PubMed ID: 21684335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic mutations shift the equilibria of alpha-synuclein single molecules towards structured conformers.
    Brucale M; Sandal M; Di Maio S; Rampioni A; Tessari I; Tosatto L; Bisaglia M; Bubacco L; Samorì B
    Chembiochem; 2009 Jan; 10(1):176-83. PubMed ID: 19067456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides.
    Di Pasquale E; Fantini J; Chahinian H; Maresca M; Taïeb N; Yahi N
    J Mol Biol; 2010 Mar; 397(1):202-18. PubMed ID: 20114052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-specific fluorescence dynamics of α-synuclein fibrils using time-resolved fluorescence studies: effect of familial Parkinson's disease-associated mutations.
    Sahay S; Anoop A; Krishnamoorthy G; Maji SK
    Biochemistry; 2014 Feb; 53(5):807-9. PubMed ID: 24450731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.